维普中文期刊产品整合服务
119篇 您的检索式:作者名="Triolo"
    题名 作者 年代 出处 被引量
1Methotrexate-induced pneumonitis in a patient with Crohn’s disease显示文摘Giovanna Margagnoni Valeria Papi Annalisa Aratari Luca Triolo Claudio Papi 2009Journal of Crohn’s and Colitis2009,,2:2
2NF-kappaB protects Behcet's disease T cells against CD95-induced apoptosls up-regulating antlapoptotic proteins显示文摘Todaro M Zerilli M Triolo G 2005Arthrit Rheum2005,52,7:1
3Clinical applications of electrical stimulation after spinal cord injury显示文摘Creasey GH Ho CH Triolo RJ 2004J Spinal Cord Med2004,27,4:1
4Functional neuromuscular stimulation in spinal cord injury显示文摘Chae J Kilgore K Triolo R 2000Phys Med Rehabil Clin N Am2000,11,:1
5N-on-covalent Complexes between DNA-binding Drugs and Double-stranded Deoxyoligonucleotides: A Study by Ionspray Mass Spectrometry显示文摘Triolo A Arcamone FM Raffaelli A 1997J Mass Spectrom1997,32,11:1
6A new algorithm to characterize biodegradability of biomass during anaerobicdigestion : influence of lignin concentration on methane production potential 显示文摘TRIOLO J M SOMMER S G MOLLER H B 2011Bioresource Technology2011,102,20:1
7Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage 显示文摘Triolo D Dina G Lorenzetti I 2006J Cell Sci2006,119,19:1
8Non-covalent Complexes Between DNA-binding Drugs and Double-stranded Deoxyoligonucleotides:A Study by Ionspray Mass Spectrometry显示文摘Triolo A Arcamone FM Raffaelli A 1997J Mass Spectrom1997,32,11:1
9IgG anti-endothelial cell antibodies(AECA) in Type I diabeticmellitus;induction of adhesion molecule expression in cultured endothelial cells显示文摘G Triolo 1998Clin Exp Immunol1998,111,:1
10Structure, Morphology and Crystallization of Random Ethylene Propylene Copolymer显示文摘Silverstre C Cimmino S Triolo R 2003J Polymer Sci Part B: Polym Phys2003,41,:1
11Dose-intensive melphalan with stem cell support(MEL100) is superior to standard treatmint in elderly myeloma patients 显示文摘Palumbo A Triolo S Argentino C 1999Blood1999,94,4:1
12中国的人工智能革命:理解中国的结构性优势显示文摘一场技术革命正席卷全世界,而能够有效利用这场革命所带来的机遇的国家将引领21世纪。这就是人工智能革命。优先掌握人工智能的国家将在制定新的全球秩序时具有至关重要的战略优势,人工智能将改变国际经济和国际关系中的势力平衡。本文通过很多证据详细地说明有关中国人工智能的情况,同时概述构成中国人工智能优势的几个主要来源。Paul Triolo 李开复 2018机器人产业2018,,1:1
13Prolonged retention of fetal bones: intrauterine device and extrauterine disease 显示文摘Panama S Triolo O Arezio P 1990Lin Exp Obstet Gynecol1990,7,1:1
14Vimentin regulates peripheral nerve myelination显示文摘Triolo D Dina G Taveggia C 2012Development2012,139,:1
15Hashimoto thyroiditis onset after laparoscopic removal of struma ovarii:an overview to unravel a rare and intriguing finding显示文摘LaganàAS Santoro G Triolo O 2015Clin Exp Obstet Gynecol2015,42,5:1
16Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study显示文摘AIM To report adalimumab(Ada) efficacy on articulargastrointestinal disease and health-related quality of life(HRQo L) in patients with enteropathic spondyloarthritis(ES).METHODS A cohort of 52 patients with ES was evaluated in the departments of gastroenterology and internal medicine. At baseline, all patients underwent assessment by an integrated gastro-rheumatologic evaluation of articular and gastrointestinal activity, as well patient reported outcomes(PROs) of the HRQo L questionnaires. After this integrated evaluation and following a specific working flowchart, the Ada anti-tumor necrosis factor(TNF)-inhibitor was assigned to a cohort of 30 patients and its clinical efficacy was evaluated at baseline and after 6-mo and 12-mo treatment by the following tests:(1) Ankylosing Spondylitis Disease Activity ScoreC-Reactive Protein(ASDAS-CRP); Bath Ankylosing Spondylitis Disease Activity Index(BASDAI), Bath Ankylosing Spondylitis Functional Index(BASFI) and Bath Ankylosing Spondylitis Metrology Index(BASMI) for articular activity;(2) Inflammatory Bowel Disease Questionnaire(IBDQ), Crohn's Disease Activity Index(CDAI) and partial Mayo(p Mayo) score for gastrointestinal symptoms and activity; and(3) Health Assessment Questionnaire(HAQ), Patient Global Assessment(PGA) and Short Form-36 health survey(SF-36) questionnaires for PROs of the HRQo L.RESULTS Integrated evaluation and management of the patients affected by ES, carried out simultaneously by a gastroenterologist and a rheumatologist, allowed clinicians to choose the optimal therapeutic strategy. In a cohort of 30 ES patients affected by active articular and gastrointestinal disease, or axial active articular inflammation, Ada led to fast and sustained improvement of both articular and gastrointestinal disease activities. In fact, all the clinimetric evaluation tests exploring articular or gastrointestinal activity, as well as all the HRQo L scores, showed a significant improvement having been achieved at the earliest(6-mo) assessment. This important clinical improvement was maintained at the 12-mo follow-up. Importantly, global and gastrointestinal quality of life significantly correlated with articular disease activity, providing evidence to support that the integrated evaluation is the best option to manage patients with ES.CONCLUSION Ada treatment, upon multidisciplinary(gastrorheumatologic) evaluation, significantly improves both articular and gastrointestinal inflammation, thereby improving the HRQo L in patients affected by ES.Michele Maria Luchetti Devis Benfaremo Francesco Ciccia Laura Bolognini Monia Ciferri Alessia Farinelli Matteo Rossini Piergiorgio Mosca Giovanni Triolo Armando Gabrielli 2017World Journal of Gastroenterology2017,23,39:1
17Bond strength and SEM evaluation of Clearfil Liner Bond 2显示文摘Barkmeier WW Los SA Triolo PT 1995Am J Dent1995,8,:1
18Susceptibility of grapevine viruses tothermotherapy on in vitro collection of Kober 5BB显示文摘PANATTONI A TRIOLO E 2010Scientia Horti-culturae2010,125,:1
19Grapevinevitivirus A eradication in Vitis vinifera explants by antiviral drugsand thermotherapy显示文摘PANATTONI A ’ D’ANNA F CRISTANIC TRIOLO E 2007J Viro Methods2007,146,:1
20Loss ofglialfibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage显示文摘Triolo D DinaG Lurenzetti I 2006J Cell SCi2006,119,:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费